With our platform technology, Cytotheryx is developing a consistent, high-quality source of primary human hepatocytes to meet the unmet need for liver cells in the life science community. In turn, these liver cells can be used in preclinical drug discovery and disease-specific research and enable therapeutic applications like liver assist devices, cell therapy, and other innovative treatments for liver disease, liver failure, and rare diseases.

Medical breakthroughs require innovative resources. Cytotheryx delivers.